Who owns PELTHOS THERAPEUTICS INC?
- Ticker: PTHS
- CUSIP Number: 171126204
Tip: Access positions for across all investors
Analyze quarterly positions in Pelthos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pelthos Therapeutics stock
Who bought or sold PELTHOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Murchinson | 290k | $9.0M | 3% | Dec 2025 |
|
| Ikarian Capital | 256k | $7.9M | 310% | Dec 2025 |
|
| Boothbay Fund Management | 81k | $2.5M | 280% | Dec 2025 |
|
| J. Goldman & Co | 78k | $2.4M | 100% | Dec 2025 |
|
| Vanguard Group | 75k | $2.3M | 12% | Dec 2025 |
|
| Cantor Fitzgerald, L. P. | 35k | $1.1M | 100% | Dec 2025 |
|
| Diadema Partners | 25k | $775k | 138% | Dec 2025 |
|
| Knott David M Jr | 19k | $598k | 215% | Dec 2025 |
|
| Geode Capital Management | 14k | $422k | 32% | Dec 2025 |
|
| Pale Fire Capital SE | 8.1k | $251k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 6.0k | $186k | 150% | Dec 2025 |
|
| Steward Partners Investment Advisory | 1.9k | $59k | 0% | Dec 2025 |
|
| UBS Group | 434.00 | $14k | 217% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.00 | $28.000000 | 100% | Sep 2025 |
|
Who sold out of Pelthos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tower Research Capital | Sep 2025 | 827.00 | $23k |